Research Management Group (RMG)

American Diabetes Association (ADA)
Pathway to Stop Diabetes
Initiator Award

$1.625M limited American Diabetes Association Initiator Award" for postdoctoral fellow -to-faculty transition award.

This is the second of two limited ADA Pathway to Stop Diabetes RFAs. The other program "Accelerator Award" is for assistant professors with PI eligibility and/or Established Investigators New to Diabetes Research (see this webpage >>)

This webpage contains the 2014 internal selection process for your reference only. A new announcement will be distributed in 2015.

# of applicants: 1 (Stanford is permitted ONE total nomination. It can be either an "Initiator" OR an "Accelerator" applicant, but not both.)

Timeline
Internal deadline: April TBA. (see the internal submission guidelines below)
Sponsor deadline: July
Start date for funding; January

Guidelines
The ADA guidelines are provided for your reference only. Please see the internal submission guidelines at the end of this message.
http://professional.diabetes.org/Diabetes_Research.aspx?typ=18&cid=93654

Amount of funding:
Awards provide two distinct phases of research support totaling up to $1.625M (2-3 awards to be made)
Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs).
Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs)**

**Phase 2 support will be approved by the Association contingent upon adequate progress in Phase 1, and receipt and approval of documentation verifying that: 1. the candidate has obtained a faculty appointment at an accredited research institution;
2. the institution has agreed to provide adequate laboratory space necessary to perform the proposed research and adequate time (75%) to dedicate to research and 3. the institution provides the candidate with an adequate and protected start-up package

Eligibility:

Purpose:
Pathway will support creative scientists early in their diabetes research careers, or investigators who are $1.625 million over the course of five to seven years, the program will allow researchers to have the freedom, autonomy, time and focus needed to explore new ideas.

Research Topics:
Pathway will consider applications directed toward topics relevant to the prevention, treatment and cure of all diabetes types (type 1, type 2 and gestational), diabetes-related disease states (obesity, pre-diabetes, and other insulin resistant states) and diabetes complications. The program intends to attract individuals with a broad range of expertise in various science and technology disciplines, including medicine, biology, chemistry, computing and engineering, to the field of diabetes research.

Research type:
You will need to indicate whether the proposed research basic, clinical, or translational. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as clinical studies of normal physiology and mechanisms of disease. Translational research is defined as research that accelerates the transition of scientific discoveries into clinical applications, by efficiently advancing knowledge of efficacy to the next level of clinical application.

Review Criteria
Scientific excellence is the primary benchmark to be evaluated for all Pathway applications, with an emphasis on the investigator’s potential to significantly impact the field of diabetes research. The proposed research strategy serves as a reflection of the individual’s capacity for innovation, creativity and collaboration.

The review will include the following components:

Principal Investigator


Research Strategy

 

Internal submission guidelines

By Apri; TBA., please submit one PDF file containing the following in the order listed below to:

Jeanne Heschele
Research Management Group (RMG)
jheschele@stanford.edu
650-245-2351

File name: Last name_ADA_Initiator_2014.pdf

Postdocs: You do not have to prepare a budget, or submit a PDRF form for the internal selection process You do not have to submit your internal proposals through your institutional representative.

1) Title Page
Title of this RFA: ADA Pathway to Stop Diabetes Diabetes Research Career Initiator (INI)
Project Title:
Indicate Diabetes Category: both Type 1 and Type 2 Diabetes; Type 1 Diabetes, Type 2 diabetes, Gestational Diabetes, Obesity, Pre-diabetes/insulin resistance
Research type: Basic, clinical, or translational
PI name, appointment, Department, address, phone, email

2) Nomination letter printed on your department or division's letterhead, prepared by your mentor and co-signed by your Division Chief or your Department Chair addressed to Dr. Peter Sarnow and the School of Medicine Awards Committee members. (These guidelines are based on the sponsor's requirement.)
Provide rationale for institution’s nomination of candidate, including why candidate is uniquely suited for the award.
Certify that the candidate has the appropriate full-time position at the sponsoring institution as required by the award.
Outline the candidate’s responsibilities and ensure that at least 75% of the nominee’s total time and effort will be allocated to research during the term of this award.
Provide assurance of an academic commitment to the candidate and to the research proposal.
Outline the institution’s plans to support the long-term development of the candidate, including specific expectations for the individual’s career course.

3) "Research Strategy" Proposal- up to 4 page maximum
Figures are allowed, but must be included in the 4 page limit.
References may be included, but may not exceed 1 page and are not included in 4 page limit.
(Formatting: based on pages 14 and 15 sponsor's guidelines-Font size 11 or larger, Ariel or Helvetica font, single-spaced margins at least one-half inch.
The research strategy should provide a high level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The Research strategy should not include a detailed project plan/methodology, and no preliminary data section is required.
The research strategy should address the following components:
a) Scientific question(s)/specific problem(s) to be addressed
b) Specific approach(es) that will be employed
c) Significance and potential impact of the work
d) The potential risks and challenges, and how they will be overcome

4) Biosketch (use an NIH biosketch, if you have one, otherwise, you can use the attached biosketch template provided by the ADA on this webpage >>)

 

Selection process
Your proposal will be reviewed by the School of Medicine Awards committee. That committee will select the ADA Pathway applicant to represent Stanford.





Stanford Medicine Resources:

Footer Links: